Latest Healthcare News

Page 104 of 160
Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.
Ada Torres
Ada Torres
20 Aug 2025
Universal Biosensors Pty Limited has entered voluntary administration with KPMG appointed as administrators, signaling urgent financial distress and a potential restructuring ahead.
Ada Torres
Ada Torres
20 Aug 2025
Monash IVF Group has completed an independent review into two separate clinic incidents involving non-standard IVF treatments, revealing human errors and IT system issues. The company commits to enhanced safeguards without expecting significant financial impact.
Ada Torres
Ada Torres
20 Aug 2025
Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.
Ada Torres
Ada Torres
20 Aug 2025
dorsaVi Ltd has unveiled Artemis Labs, a new subsidiary focused on developing advanced AI, sensor, and robotics technologies powered by cutting-edge RRAM. This initiative aims to transform human movement data into intelligent robotic and healthcare applications.
Sophie Babbage
Sophie Babbage
20 Aug 2025
Dexus posted a 5.4% rise in revenue for FY25 but reported a substantial net loss driven by impairments, while increasing distributions to security holders.
Eva Park
Eva Park
20 Aug 2025
Centuria Capital Group has outperformed its FY25 earnings guidance, reporting a 4.3% rise in operating EPS and announcing ambitious FY26 growth targets alongside the launch of Australia’s first public sovereign AI Factory.
Eva Park
Eva Park
19 Aug 2025
Centuria Capital Group reported a robust FY25 with $19.7 billion in assets under management and earnings per stapled security exceeding guidance. The group is poised for strong FY26 growth, driven by stabilizing real estate markets and its pioneering sovereign AI Factory.
Eva Park
Eva Park
19 Aug 2025
CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.
Ada Torres
Ada Torres
19 Aug 2025
CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.
Ada Torres
Ada Torres
19 Aug 2025
Regal Asian Investments Limited posted a sharp 92% decline in net profit for FY25 amid volatile Asian markets but maintained a fully franked 6 cent dividend and continued its on-market share buy-back program.
Victor Sage
Victor Sage
18 Aug 2025
Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.
Ada Torres
Ada Torres
18 Aug 2025